4.3 Article

Interleukin-25 Induces Pulmonary Arterial Remodeling via Natural Killer T Cell-Dependent Mechanisms

期刊

出版社

KARGER
DOI: 10.1159/000350379

关键词

Interleukin-25; Pulmonary arterial remodeling; Natural killer T cells

资金

  1. Ministry of Education, Culture, Sports, Science and Technology
  2. Japanese Government
  3. Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan

向作者/读者索取更多资源

Background: Recent studies have shown that prolonged Th2-type immune inflammation in the lung induces pulmonary arterial remodeling, in part through the induction of resistin-like molecule alpha (RELM alpha) expression. However, the role of interleukin-25 (IL-25; which promotes this inflammation) in the development of the pulmonary arterial remodeling remains unknown. Methods: Ovalbumin (OVA)-sensitized C57BL/6 mice were challenged with OVA inhalation 3 times a week for 3 weeks. The effects of neutralizing antiIL- 25 antibody on OVA-induced pulmonary arterial remodeling and RELMa expression in the lung were examined. The pulmonary arterial remodeling and RELMa expression in the lung were examined in lung-specific IL-25 transgenic mice (CC10 IL-25 mice) and CC10 IL-25 mice in a natural killer T (NKT) cell-deficient background (CC10 IL-25 NKT-/- mice). Results: Repeated OVA inhalation induced pulmonary arterial wall thickening and the expression of IL-25 and RELMa mRNA in the lung in OVA-sensitized mice. Injection of neutralizing anti-IL-25 antibody inhibited OVA-induced pulmonary arterial wall thickening and RELMa expression in the lung. CC10 IL-25 mice, but not CC10 IL-25 NKT-/- mice, spontaneously developed pulmonary arterial wall thickening and RELMa expression in the lung at 6 months of age. Conclusions: Prolonged expression of IL-25 in the lung induces pulmonary arterial wall thickening by NKT cell-dependent mechanisms. Copyright (C) 2013 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Prognosis and Treatment of Myositis-Associated Severe Interstitial Lung Disease: A Descriptive Study Using a Nationwide Inpatient Database in Japan

Hiroki Furuya, Mikio Nakajima, Kei Ikeda, Kaito Nakamura, Hiroyuki Ohbe, Shotaro Aso, Ryosuke Kumazawa, Taro Iwamoto, Arifumi Iwata, Shunsuke Furuta, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga, Hiroshi Nakajima

Summary: This study aimed to investigate the prognosis, clinical course, and management of severe interstitial lung disease (ILD) associated with myositis. The results showed that despite aggressive interventions, the mortality rate of myositis-associated ILD patients requiring mechanical ventilation is extremely high, with a significantly higher mortality rate in patients with dermatomyositis (DM) compared to those with polymyositis (PM).

ARTHRITIS CARE & RESEARCH (2022)

Review Immunology

Epigenetic regulation of inflammation by CxxC domain-containing proteins*

Atsushi Onodera, Masahiro Kiuchi, Kota Kokubo, Toshinori Nakayama

Summary: Epigenetic regulation is crucial for controlling inflammation in the immune system, with CxxC domain-containing proteins playing important roles as epigenetic readers and writers. By binding to non-methylated CpG sites, these proteins contribute to proper immune cell function and regulation in both T cells and macrophages.

IMMUNOLOGICAL REVIEWS (2022)

Article Rheumatology

Seasonal exacerbation of rheumatoid arthritis detected by big claims data analysis: A retrospective population study

Fumihiko Ando, Katsuhiko Takabayashi, Shinsuke Fujita, Hiroshi Nakajima, Hideki Hanaoka, Takahiro Suzuki

Summary: This study investigated the seasonal changes in the use of biological disease-modifying antirheumatic drugs (bDMARDs) and methotrexate (MTX), and found that their use was highest in spring and lowest in winter. These seasonal changes are often overlooked in daily practice.

MODERN RHEUMATOLOGY (2023)

Article Rheumatology

Antiphospholipid antibody positivity and the thrombotic risk in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis

Junya Suzuki, Shunsuke Furuta, Takahiro Sugiyama, Taro Iwamoto, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima

Summary: This study retrospectively assessed the proportion of aPL positivity and its association with thrombotic risk in Japanese patients with AAV. The results showed that 33.3% of the patients were aPL-positive, and aPL positivity was associated with a higher incidence of thrombotic events. Multivariate analyses confirmed aPL positivity as a risk factor for thrombosis.

MODERN RHEUMATOLOGY (2023)

Article Chemistry, Analytical

Rapid and quantitative detection of multiple antibodies against SARS-CoV-2 mutant proteins by photo-immobilized microarray

Jun Akimoto, Hiroharu Kashiwagi, Nobuhiro Morishima, Sei Obuse, Takashi Isoshima, Takahiro Kageyama, Hiroshi Nakajima, Yoshihiro Ito

Summary: A rapid automatic diagnostic system for multiple SARS-CoV-2 mutant protein-specific antibodies was developed using a microarray with photoreactive polymers. The system showed high correlation with conventional enzyme-linked immunoassay or immunochromatography, and was successfully used for testing sera or blood from recovered patients and vaccinated individuals, with good detection efficiency for virus mutation.

ANALYTICAL SCIENCES (2022)

Article Infectious Diseases

Antibody responses and SARS-CoV-2 infection after BNT162b2 mRNA booster vaccination among healthcare workers in Japan

Hidetoshi Igari, Haruna Asano, Shota Murata, Toshihiko Yoshida, Kenji Kawasaki, Takahiro Kageyama, Key Ikeda, Hiromi Koshikawa, Yoshio Okuda, Misao Urushihara, Hitoshi Chiba, Misuzu Yahaba, Toshibumi Taniguchi, Kazuyuki Matsushita, Ichiro Yoshino, Koutaro Yokote, Hiroshi Nakajima

Summary: Booster vaccination can increase antibody levels and reduce the risk of SARS-CoV-2 infection. Healthcare workers in COVID-19 wards and individuals aged 20-49 are more susceptible to infection.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2022)

Article Multidisciplinary Sciences

Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity

Chiaki Iwamura, Kiyoshi Hirahara, Masahiro Kiuchi, Sanae Ikehara, Kazuhiko Azuma, Tadanaga Shimada, Sachiko Kuriyama, Syota Ohki, Emiri Yamamoto, Yosuke Inaba, Yuki Shiko, Ami Aoki, Kota Kokubo, Rui Hirasawa, Takahisa Hishiya, Kaori Tsuji, Tetsutaro Nagaoka, Satoru Ishkawa, Akira Kojima, Haruki Mito, Ryota Hase, Yasunori Kasahara, Naohide Kuriyama, Tetsuya Tsukamoto, Sukeyuki Nakamura, Takashi Urushibara, Satoru Kaneda, Seiichiro Sakao, Minoru Tobiume, Yoshio Suzuki, Mitsuhiro Tsujiwaki, Terufumi Kubo, Tadashi Hasegawa, Hiroshi Nakase, Osamu Nishida, Kazuhisa Takahashi, Komei Baba, Yoko Iizumi, Toshiya Okazaki, Motoko Y. Kimura, Ichiro Yoshino, Hidetoshi Igari, Hiroshi Nakajima, Takuji Suzuki, Hideki Hanaoka, Taka-aki Nakada, Yuzuru Ikehara, Koutaro Yokote, Toshinori Nakayama

Summary: This study investigates the pathogenesis of vasculitis and immunothrombosis in COVID-19, finding that SARS-CoV-2 accumulates in pulmonary vessels and causes vasculitis and microthrombi formation. The amount of plasma Myl9 is correlated with disease severity, and measuring plasma Myl9 together with other markers allows for a more accurate prediction of disease severity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biochemistry & Molecular Biology

A20 (Tnfaip3) expressed in CD4+ T cells suppresses Th2 cell-mediated allergic airway inflammation in mice

Yusuke Yokoyama, Tomohiro Tamachi, Arifumi Iwata, Yuko Maezawa, Kazuyuki Meguro, Masaya Yokota, Hiroaki Takatori, Akira Suto, Kotaro Suzuki, Koichi Hirose, Noritaka Yamaguchi, Hiroaki Honda, Hiroshi Nakajima

Summary: A20, a ubiquitin-editing enzyme, inhibits NF-kB signaling pathways and has anti-inflammatory effects. Studies have found that the expression of A20 in T cells is associated with asthmatic responses, particularly in the regulation of Th2 cell differentiation.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Letter Infectious Diseases

Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine

Yoichi Mashimo, Keiko Yamazaki, Takahiro Kageyama, Shigeru Tanaka, Toshibumi Taniguchi, Kazuyuki Matsushita, Hidetoshi Igari, Hideki Hanaoka, Koutaro Yokote, Hiroshi Nakajima, Yoshihiro Onouchi

JOURNAL OF INFECTION (2022)

Review Rheumatology

Fulminant myocarditis with adult-onset Still's disease: case-based review

Ryohei Ono, Togo Iwahana, Shuji Toriumi, Kaoruko Aoki, Hirotoshi Kato, Kodai Kato, Masahiro Yasui, Yuzuho Nakagawa, Shunsuke Furuta, Hiroshi Nakajima, Yoshio Kobayashi

Summary: This study reports a rare case of a 43-year-old female with fulminant myocarditis with adult-onset Still's disease (AOSD). The patient had refractory AOSD and cardiogenic shock with significantly elevated ferritin levels. The case was successfully treated with canakinumab and mechanical circulatory support. A review of previous cases shows that myocarditis may be an early complication of AOSD, and the severity of AOSD may correlate with the severity of myocarditis.

CLINICAL RHEUMATOLOGY (2023)

Article Rheumatology

Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort study

Norihiro Mimura, Taro Iwamoto, Shunsuke Furuta, Kei Ikeda, Yoshihisa Kobayashi, Takayuki Nakamura, Aiko Saku, Shin-Ichiro Kagami, Ayako Matsuki, Kentaro Takahashi, Takeshi Umibe, Daiki Nakagomi, Yoshie Sanayama, Toyohiko Sugimoto, Masashi Fukuta, Masaki Hiraguri, Hirotoshi Kawashima, Koichi Hirose, Hiroaki Takatori, Kenichi Suehiro, Shigekazu Takahashi, Tomohiro Tamachi, Manami Kato, Fumiyoshi Takizawa, Yuya Kawarai, Shigeo Hagiwara, Junichi Nakamura, Seiji Ohtori, Hiroshi Nakajima

Summary: Objective: To determine the prevalence and risk factors for osteonecrosis of the femoral head (ONFH) in AAV patients. Methods: Assessment of 186 AAV patients for the presence of ONFH through radiographs and MRI screening. Results: 18% of AAV patients were diagnosed with ONFH, and 64% of them had bilateral ONFH. Prednisolone dose of >= 20 mg/day on day 90 of RIT was identified as an independent risk factor for ONFH. Conclusion: Early detection of precollapse ONFH by MRI and rapid reduction of glucocorticoids in RIT may help prevent the development of ONFH in AAV patients.

RMD OPEN (2023)

Article Rheumatology

Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study

Kazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, Takao Sugiyama, Shin-Ichiro Kagami, Daiki Nakagomi, Taro Iwamoto, Kei Ikeda, Hiroshi Nakajima

Summary: This study aimed to assess the association between spontaneous pneumomediastinum (SPNM) occurrence and mortality in myositis patients with interstitial lung disease (ILD) according to antimelanoma differentiation-associated gene 5 (MDA5) antibody status. The results showed that SPNM was more common in myositis patients who were anti-MDA5 antibody positive, and it was associated with a higher risk of mortality.

RMD OPEN (2023)

Article Rheumatology

Visceral disseminated varicella zoster virus infection during non-intensive maintenance therapy in a patient with systemic lupus erythematosus

Koto Hattori, Shigeru Tanaka, Junichi Ishikawa, Yoko Yabe, Taro Iwamoto, Shunsuke Furuta, Kei Ikeda, Kotaro Suzuki, Hiroshi Nakajima

Summary: This case report describes a SLE patient who developed VD-VZV during hospitalization. The patient presented with vesicular eruption and subsequent testing confirmed VD-VZV infection.

MODERN RHEUMATOLOGY CASE REPORTS (2023)

Article Rheumatology

Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium

Jumpei Shoda, Shigeru Tanaka, Keishi Etori, Koto Hattori, Tadamichi Kasuya, Kei Ikeda, Yuko Maezawa, Akira Suto, Kotaro Suzuki, Junichi Nakamura, Yoshiro Maezawa, Minoru Takemoto, Christer Betsholtz, Koutaro Yokote, Seiji Ohtori, Hiroshi Nakajima

Summary: The expression of semaphorin 3G in CD4(+) T cells is downregulated by MTX treatment in patients with RA, while upregulation of semaphorin 3G in the RA synovium exacerbates joint inflammation through the accumulation of macrophages.

ARTHRITIS RESEARCH & THERAPY (2022)

Article Rheumatology

Latent class analysis of 216 patients with adult-onset Still's disease

Takahiro Sugiyama, Shunsuke Furuta, Masaki Hiraguri, Kei Ikeda, Yosuke Inaba, Shin-Ichiro Kagami, Yasuhiko Kita, Kei Kobayashi, Yoshihisa Kobayashi, Kazuhiro Kurasawa, Daiki Nakagomi, Yasushi Nawata, Yohei Kawasaki, Yuki Shiko, Takao Sugiyama, Hiroshi Nakajima

Summary: This study identified two subgroups of Adult-onset Still's disease (AOSD): the typical group and the elderly-onset group. Although the survival of AOSD patients was generally good, they often experienced relapses. Age >= 65 years at disease onset was identified as a risk factor for relapse.

ARTHRITIS RESEARCH & THERAPY (2022)

暂无数据